Staar Surgical Co (STAA) 7.01 $STAA Long Term STAAR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Staar Surgical Co (STAA) 7.01 $STAA

Long Term STAAR Investors: Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigation of STAAR Surgical Company; Encourages Long Term Investors to Contact the Firm
PR Newswire - Wed Jul 06, 8:40AM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal and state securities laws by STAAR Surgical Company (NASDAQ: STAA) and certain of its officers and board members. STAAR designs, develops, manufactures and sells implantable lenses for the eye and delivery systems to deliver the lenses into the eye.
STAA: 7.01 (+0.17)

Lifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc., LinkedIn Corporation, Mines Management, Inc., Rose Rock Midstream, L.P., STAAR Surgical Company, XenoPort, Inc. and Your Community Bankshares, Inc.
PR Newswire - Mon Jun 20, 11:52AM CDT
Exterran Corporation (EXTN) Lifshitz & Miller announces investigation on behalf of Exterran investors. Specifically, on April 26, 2016, Exterran announced it will restate its consolidated and combined financial statements for 2015 and expects to delay the filing of its Form 10-Q for the quarter ended March 31, 2016.
EXTN: 12.35 (-0.37), LNKD: 192.95 (+0.22), SAAS: 13.89 (-0.01), STAA: 7.01 (+0.17), YCB: 37.51 (+0.30), RRMS: 22.54 (-0.97), MGN: 1.44 (+0.04), XNPT: 7.07 (+0.05)

The Shuman Law Firm Investigates STAAR Surgical Company
BusinessWire - Thu Jun 09, 1:00PM CDT
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of STAAR Surgical Company ("STAAR" or the "Company" (Nasdaq: STAA). STAAR is a Monrovia, CA-based company that designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.
STAA: 7.01 (+0.17)

Update in Lawsuit for Investors in STAAR Surgical Company (NASDAQ:STAA) shares announced by Shareholders Foundation
GlobeNewswire - Tue May 17, 8:45AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit is pending in California on behalf of certain purchasers of shares of STAAR Surgical Company (NASDAQ:STAA) over alleged Securities Laws Violations by STAAR Surgical.
STAA: 7.01 (+0.17)

STAAR Surgical Announces Approval By Health Canada of Its EVO Visian ICL(TM) for Surgeons and Their Patients in Canada
PR Newswire - Fri May 13, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, was notified yesterday of the approval of its EVO Visian ICL, STAAR's Implantable Collamer® Lens, for distribution in Canada by the Medical Devices Bureau of Health Canada.
STAA: 7.01 (+0.17)

Downgrade Alert for STAAR Surgical (STAA)
Comtex SmarTrend(R) - Fri May 13, 3:24AM CDT
STAAR Surgical (NASDAQ:STAA) was downgraded from Overweight to Equal Weight at Stephens today. The stock closed yesterday at $5.65 on volume of 682,000 shares, above average daily volume of 88,000. Over the past year, STAAR Surgical has traded in a range of $6.00 to $10.76 and closed yesterday at $5.65, -6% above that low. The 200-day and 50-day moving averages have moved 0.47% lower and 1.50% higher over the past week, respectively.
STAA: 7.01 (+0.17)

Staar Surgical reports 1Q loss
Automated Insights - Wed May 11, 3:18PM CDT
MONROVIA, Calif. (AP) _ Staar Surgical Co. (STAA) on Wednesday reported a loss of $8 million in its first quarter.
STAA: 7.01 (+0.17)

STAAR Surgical Reports First Quarter 2016 Results
PR Newswire - Wed May 11, 3:01PM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye today reported financial results for the first quarter ended April 1, 2016.
STAA: 7.01 (+0.17)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 3.58 (-0.12), STAA: 7.01 (+0.17), AKER: 2.99 (-0.05), VBLT: 4.01 (-0.01)

STAAR Surgical to Report First Quarter Results on May 11, 2016
PR Newswire - Tue Apr 26, 12:14PM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 1, 2016 and provide an update on activities at this year's ASCRS annual meeting on Wednesday, May 11, 2016 after the market close.
STAA: 7.01 (+0.17)

How STAAR Surgical (STAA) Stock Stands Out in a Strong Industry
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 7:41AM CST
STAAR Surgical is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
STAA: 7.01 (+0.17)

16.3% Return Seen to Date on SmarTrend STAAR Surgical Call (STAA)
Comtex SmarTrend(R) - Tue Feb 09, 10:34AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on October 27th, 2015 at $7.39. In approximately 4 months, STAAR Surgical has returned 16.32% as of today's recent price of $6.18.
STAA: 7.01 (+0.17)

STAAR Surgical Company and Memira Holding Announce Cooperation Agreement for Memira's Eye Clinics throughout Scandinavia
PR Newswire - Tue Feb 09, 6:00AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, and Memira Holding, Sweden, today announced they have entered into an agreement effective January 1, 2016, to provide STAAR's phakic intraocular lenses (ICL) as a primary and premium option for refractive eye treatment.
STAA: 7.01 (+0.17)

Commit To Buy Staar Surgical At $5, Earn 14.9% Annualized Using Options
StockOptionsChannel.com - Mon Feb 08, 10:46AM CST
Investors eyeing a purchase of Staar Surgical Co. shares, but cautious about paying the going market price of $6.14/share, might benefit from considering selling puts among the alternative strategies at their disposal.
STAA: 7.01 (+0.17)

Becton, Dickinson Beats Q1 Earnings, FY16 View Raised
Zacks Equity Research - Zacks Investment Research - Wed Feb 03, 9:40AM CST
Becton, Dickinson and Company (BDX), popularly known as BD, reported first-quarter fiscal 2016 earnings of $1.96 per share, which beat the Zacks Consensus Estimate by 12 cents.
DSCI: 4.74 (-0.03), BDX: 177.38 (+1.38), STAA: 7.01 (+0.17), PDCO: 49.53 (+0.17)

STAAR Surgical to Report Fourth Quarter Results on March 2, 2016
PR Newswire - Wed Feb 03, 6:00AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the fourth quarter ended January 1, 2016 on Wednesday, March 2, 2016 after the market close.
STAA: 7.01 (+0.17)

Baxter International Crushes Q4 Earnings on Solid Margins
Zacks Equity Research - Zacks Investment Research - Tue Feb 02, 12:37PM CST
Baxter International Inc (BAX) reported fourth-quarter 2015 adjusted earnings of 43 cents per share, which outpaced the Zacks Consensus Estimate by 12 cents.
STAA: 7.01 (+0.17), BAX: 48.61 (+0.59), LMAT: 17.70 (+0.50), VASC: 46.59 (+0.72)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Choice Hotels Unveils Comprehensive Sustainability Efforts

Updated Category News Views 387

Choice Hotels International Launches 2024 Sustainability Report Choice Hotels International, Inc. (NYSE: CHH), a leading global lodging franchisor, has officially released its 2024 Sustainability Report, showcasing its ongoing commitment to environmental sustainability. The report highlights the company's innovative approaches to reducing its carbon footprint and...

Continue Reading
Revitalizing Communities Through Skilled Trades Initiatives

Updated Category News Views 157

Revitalizing Communities Through Skilled Trades Initiatives In an important moment for many towns across America that are striving for renewal, a new initiative has emerged to shine a light on the necessity of skilled trades. The campaign, titled Careers in Manufacturing, is aimed at highlighting how vital these trades are for both local economies and the workforce on the...

Continue Reading
Color Me Mine Celebrates Growth and Franchise Success

Updated Category News Views 344

Color Me Mine Achieves Remarkable Mid-Year Growth Color Me Mine, a leading paint-your-own pottery franchise, is excited to announce significant growth through its studio expansion and franchisee success. The brand is witnessing a thriving landscape of opportunities, fueled by enthusiastic franchise owners who are making their mark in various communities. Studio Expansion...

Continue Reading
Earnings Insights: Companies Set to Report Soon

Updated Category News Views 202

Upcoming Earnings Reports for Major Companies As the earnings season approaches, investors and analysts eagerly anticipate the financial results from several prominent companies. This article highlights some of the key players expected to announce their quarterly results. Companies Reporting Before the Market Opens UP Fintech Holding (TIGR) UP Fintech Holding is projected...

Continue Reading
Cogent Biosciences Shares Insights at Prestigious Healthcare Event

Updated Category News Views 207

Cogent Biosciences Highlights Participation in Major Healthcare Conference Cogent Biosciences, Inc. (Nasdaq: COGT), a pioneering biotechnology company, is ready to showcase its innovative approach to precision medicine at the highly regarded J.P. Morgan Healthcare Conference. Taking place in San Francisco, this annual event is a crucial platform for industry leaders to...

Continue Reading